Morningstar

Kenvue Inc KVUE

Stock XNYS Rating as of Oct 27, 2026

News

Kimberly-Clark Corporation Announces Extension of the Expiration Date for Exchange Offers for Kenvue Notes

PR Newswire Oct 28, 2026, 1:29:00 AM
Kenvue to Announce Third Quarter 2026 Results on October 30, 2026

Business Wire Oct 21, 2026, 9:00:00 PM
Kimberly-Clark Announces Successful Consent Solicitations for Kenvue Notes and Amendment to Terms of Exchange Offers

PR Newswire Oct 13, 2026, 11:00:00 AM
Kimberly-Clark Announces Planned Executive Transitions and Updates to Post-Closing Leadership Team

PR Newswire Oct 1, 2026, 11:00:00 AM
LISTERINE® Launches Oral Care Counts This World Smile Day as Oral Disease Cases Rise to 3.73 Billion

Business Wire Oct 1, 2026, 10:45:00 AM
Neutrogena®, Aveeno®, and Regaine® Present New Scientific Evidence Demonstrating How Science-Backed Ingredients Support Healthy Skin and Hair

Business Wire Sep 30, 2026, 10:45:00 AM
Kimberly-Clark Corporation Announces Commencement of Exchange Offers and Consent Solicitations for Kenvue Notes

PR Newswire Sep 28, 2026, 8:05:00 PM
Kenvue Declares Quarterly Cash Dividend

Business Wire Sep 10, 2026, 10:45:00 AM
Kimberly-Clark Appoints Suzana Blades as Senior Vice President and General Counsel

PR Newswire Aug 13, 2026, 1:25:00 PM
Kenvue Reports Second Quarter 2026 Results

Business Wire Aug 6, 2026, 10:45:00 AM
Could Huggies and Tylenol be a good fit? Kimberly-Clark is buying Kenvue for $48 billion

MarketWatch Nov 3, 2025, 6:26:00 PM
Kenvue Urges FDA to Reject Request for Autism Warning on Tylenol

Global News Select Oct 20, 2025, 5:30:00 PM
Johnson & Johnson's stock heads for a record after a profit beat and plans for another spinoff

MarketWatch Oct 14, 2025, 11:44:00 AM
Kenvue stock rallies off record low after Trump press conference on alleged Tylenol-autism link

MarketWatch Sep 23, 2025, 2:33:00 PM

Sponsor Center

Transparency is our policy. Learn how it impacts everything we do

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

How we make money

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your personal data

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

Verify your identity, personalize the content you receive, or create and administer your account.
Provide specific products and services to you, such as portfolio management or data aggregation.
Develop and improve features of our offerings.
Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

How we approach editorial content

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.

© Copyright 2026 Morningstar, Inc. All rights reserved. Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.